Influenza virus infection and aerosol shedding kinetics in a controlled human infection model
2024

Influenza Virus Infection and Shedding in Humans

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Nishit Shetty, Meredith J. Shephard, Nicole C. Rockey, Hollie Macenczak, Jessica Traenkner, Shamika Danzy, Nahara Vargas-Maldonado, Peter J. Arts, Valerie Le Sage, Evan J. Anderson, G. Marshall Lyon, Eric Charles Fitts, Dalia A. Gulick, Aneesh K. Mehta, Mikhael F. El-Chami, Colleen S. Kraft, Krista R. Wigginton, Anice C. Lowen, Linsey C. Marr, Nadine G. Rouphael, Seema S. Lakdawala

Primary Institution: Emory University

Hypothesis

What are the dynamics of influenza virus shedding and symptom progression in a controlled human infection model?

Conclusion

The study demonstrates the safety and utility of a controlled human infection model to study influenza virus transmission dynamics.

Supporting Evidence

  • Six out of eight participants were confirmed to be infected with the influenza virus.
  • Viral shedding was observed in multiple physiological compartments including saliva and aerosols.
  • Participants with higher viral loads showed a significant increase in antibody titers by day 15.

Takeaway

Researchers studied how the flu spreads by infecting eight volunteers and watching how they got sick and shed the virus.

Methodology

Participants were intranasally inoculated with H3N2 influenza virus, and symptoms and viral shedding were monitored over 15 days.

Potential Biases

Potential bias in participant selection and reporting of symptoms.

Limitations

The small sample size and the controlled environment may not fully represent natural infection dynamics.

Participant Demographics

Participants were aged 20 to 45, with a mix of races and ethnicities.

Digital Object Identifier (DOI)

10.1128/jvi.01612-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication